Pierre Fabre Partners with XtalPi on AI-Driven Drug Discovery

Laboratoires Pierre Fabre and XtalPi announced an agreement on November 9, 2026 to use XtalPi's AI and robotics to discover novel small-molecule clinical candidates across multiple research programs.

Read the full story at Unite.AI ↗

Timeline · 1 report

2026-11-09 09:54 · Unite.AI
Pierre Fabre Taps XtalPi’s AI and Robotics for Drug Discovery

More stories

Nvidia board opens independent probe after CEO Jensen Huang admits affair with suspected Chinese spy — Axios AI+
NVIDIA Announces Planned Investments in Korean Startups at MSIT Partnership Forum — NVIDIA Blog
NVIDIA, Rebellions and SK Telecom partner on Korea's sovereign AI infrastructure — NVIDIA Newsroom
Anthropic agrees $3.4bn deal for gas-fired generators to power AI data centres — Financial Times AI
Asian markets bounce back after a recovery for AI stocks on Wall Street — The Globe and Mail
Effective Altruism Movement Seeks to Reshape Its Public Image Amid AI Criticism — Barron's
STATERA Library expands Path Planning and Autonomous Navigation series with chapters 18-25 — DEV Community — AI
Hydra-PSIE expands DOI registry to 42 works under Coeziune OM-IA banner — DEV Community — AI

Get the daily brief of stories like this at 6:30 every morning →